NCT07342530 Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy
| NCT ID | NCT07342530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Written Exposure Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-03-09 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 * Delivered a live infant within 5 days * Severe maternal morbidity or infant admitted to NICU * PCL-5 ≥28 * English-speaking * Able to consent and participate Exclusion Criteria: * Active psychosis or mania * Current suicidal crisis * Current suicidal intent or plan * Cognitive impairment preventing participation
Contact & Investigator
Pervez Sultan
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07342530 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Written Exposure Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342530 currently recruiting?
Yes, NCT07342530 is actively recruiting participants. Visit ClinicalTrials.gov or contact Stanford University to inquire about joining.
Where is the NCT07342530 trial being conducted?
This trial is being conducted at Little Rock, United States, Palo Alto, United States.
Who is sponsoring the NCT07342530 clinical trial?
NCT07342530 is sponsored by Stanford University. The principal investigator is Pervez Sultan at Stanford University. The trial plans to enroll 70 participants.